CHLORHEXIDINE ACETATE
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
18-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CHLORHEXIDINE DIACETATE
Available from:
Baxter Healthcare Limited
Dosage:
0.05 %w/v
Pharmaceutical form:
Cutaneous Solution
Authorization date:
1986-09-30
Summary of Product characteristics
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Chlorhexidine Acetate BP 0.05% w/v for Irrigation, 250 ml.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Chlorhexidine Acetate 0.05% w/v
3 PHARMACEUTICAL FORM
Cutaneous irrigation solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As a disinfectant for topical irrigation of wounds or burns.
For disinfection of respirators.
4.2 POSOLOGY AND METHOD OF ADMINSTRATION
4.2.1. DOSAGE
The dosage is dependant upon the age, weight and
clinical condition of the patient
4.2.2. ADMINISTRATION
For topical use only.
4.3 CONTRAINDICATIONS
This solution must not come into contact with the brain
meninges, perforated ear drum or eyes. This solution is not
recommended for bladder irrigation. Use in patients with known
hypersensitivity to Chlorhexidine, not for use in
abdominal cavities, unless under supervision of a specialist.
4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
This solution should not be taken orally. This solution
is not for intravenous administration. Accidental ingestion
should be treated with a stomach lavage consisting of milk, egg
white, gelatine or mild soap. Idiosyncratic reactions to
Chlorhexidine Acetate BP have been reported.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
Not applicable.
4.6 PREGNANCY AND LACTATION
This product should not be used during pregnancy
unless considered essential by the physician.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Issued 18/11/2005_
_CRN 2016954_
_page number: 1_
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable.
4.8 UNDESIRABLE EFFECTS
Not applicable.
4.9 OVERDOSE
Not applicable.
5 PHARMACOLOGICAL PROPERTIES
5.1 PHARMACODYNAMIC PROPERTIES
Not applicable.
5.2 PHARMACOKINETIC
Read the complete document
